​

Insight Molecular Diagnostics (IMDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Insight Molecular Diagnostics Revenue Highlights

Latest Revenue (Y)

$4.05M

Latest Revenue (Q)

$260.00K

Main Segment (Y)

Laboratory Services

Main Geography (Y)

UNITED STATES

Insight Molecular Diagnostics Revenue by Period

Insight Molecular Diagnostics Revenue by Year

DateRevenueChange
2025-12-31$4.05M115.58%
2024-12-31$1.88M25.15%
2023-12-31$1.50M56.89%
2022-12-31$958.00K-56.41%
2021-12-31$2.20M80.76%
2020-12-31$1.22M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--

Insight Molecular Diagnostics generated $4.05M in revenue during NA 2025, up 115.58% compared to the previous quarter, and up 333.47% compared to the same period a year ago.

Insight Molecular Diagnostics Revenue by Quarter

DateRevenueChange
2025-09-30$260.00K-49.81%
2025-06-30$518.00K-75.77%
2025-03-31$2.14M43.88%
2024-12-31$1.49M1192.17%
2024-09-30$115.00K10.58%
2024-06-30$104.00K-40.91%
2024-03-31$176.00K-43.95%
2023-12-31$314.00K-26.81%
2023-09-30$429.00K-7.34%
2023-06-30$463.00K55.89%
2023-03-31$297.00K-108.37%
2022-12-31$-3.55M-449.07%
2022-09-30$1.02M-50.80%
2022-06-30$2.07M45.15%
2022-03-31$1.42M-60.32%
2021-12-31$3.59M264.74%
2021-09-30$984.00K-51.53%
2021-06-30$2.03M80.60%
2021-03-31$1.12M123.46%
2020-12-31$503.00K-9.37%
2020-09-30$555.00K288.11%
2020-06-30$143.00K793.75%
2020-03-31$16.00K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31--

Insight Molecular Diagnostics generated $260.00K in revenue during Q3 2025, up -49.81% compared to the previous quarter, and up 250.00% compared to the same period a year ago.

Insight Molecular Diagnostics Revenue Breakdown

Insight Molecular Diagnostics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Laboratory Services$4.03M-
Pharma Services-$1.86M

Insight Molecular Diagnostics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Laboratory Services (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Jun 25Mar 25
Laboratory Services$3.54M$494.00K-
Pharma Services--$2.14M

Insight Molecular Diagnostics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Laboratory Services (100.00%).

Insight Molecular Diagnostics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24
Europe$24.00K-
UNITED STATES$4.03M$1.67M
GERMANY-$18.00K
Asia Pacific-$145.00K

Insight Molecular Diagnostics's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (99.41%), and Europe (0.59%).

Quarterly Revenue by Country

CountryDec 25Jun 25Mar 25
Europe-$24.00K-
UNITED STATES$1.40M$494.00K$2.14M

Insight Molecular Diagnostics's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (100.00%).

Insight Molecular Diagnostics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CDXSCodexis$70.39M$15.25M
SGMOSangamo Therapeutics$57.80M$581.00K
IVVDInvivyd$53.43M$13.13M
OABIOmniAb$18.67M$14.43M
PRLDPrelude Therapeutics$12.14M$6.50M
IMDXInsight Molecular Diagnostics$4.05M$260.00K
MISTMilestone Pharmaceuticals$1.55M-
CCCCC4 Therapeutics--
PEPGPepGen--

IMDX Revenue FAQ

What is Insight Molecular Diagnostics’s yearly revenue?

Insight Molecular Diagnostics's yearly revenue for 2025 was $4.06M, representing an increase of 115.58% compared to 2024. The company's yearly revenue for 2024 was $1.88M, representing an increase of 25.15% compared to 2023. IMDX's yearly revenue for 2023 was $1.5M, representing an increase of 56.89% compared to 2022.

What is Insight Molecular Diagnostics’s quarterly revenue?

Insight Molecular Diagnostics's quarterly revenue for Q3 2025 was $260K, a -49.81% decrease from the previous quarter (Q2 2025), and a 126.09% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $518K, a -75.77% decrease from the previous quarter (Q1 2025), and a 398.08% increase year-over-year (Q2 2024). IMDX's quarterly revenue for Q1 2025 was $2.14M, a 43.88% increase from the previous quarter (Q4 2024), and a 1114.77% increase year-over-year (Q1 2024).

What is Insight Molecular Diagnostics’s revenue growth rate?

Insight Molecular Diagnostics's revenue growth rate for the last 3 years (2023-2025) was 169.79%, and for the last 5 years (2021-2025) was 84.49%.

What are Insight Molecular Diagnostics’s revenue streams?

Insight Molecular Diagnostics's revenue streams in c 25 are Laboratory Services

What is Insight Molecular Diagnostics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Insight Molecular Diagnostics was Laboratory Services. This segment made a revenue of $4.03M, representing 100.00% of the company's total revenue.